UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between breast cancer and prostate cancer clinical trials and research opportunities
The most common UK cancer in women (~55,000 cases). Extensive biomarker subtyping (HER2, HR, TNBC) creates diverse trial opportunities.
The most common UK cancer in men (~52,000 cases). PSMA-targeted therapies and hormone treatment sequencing drive active research.
Both are hormone-driven cancers with established screening. Breast cancer has more molecular subtypes driving trial diversity. Prostate trials focus heavily on treatment sequencing.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
